TY - JOUR
T1 - Frequency and type of premature or early menopause in a geographically defined American population
AU - Rocca, Walter A.
AU - Gazzuola Rocca, Liliana
AU - Smith, Carin Y.
AU - Kapoor, Ekta
AU - Faubion, Stephanie S.
AU - Stewart, Elizabeth A.
N1 - Funding Information:
Funding for this study was provided by the grants U54 AG044170 and RF1 AG055151 from the National Institute on Aging/National Institutes of Health. In addition, this study used the resources of the Rochester Epidemiology Project (REP) medical records-linkage system, which is supported by the National Institute on Aging (R33 AG058738), by the Mayo Clinic Research Committee, and by fees paid annually by REP users. However, the content of this article is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health (NIH) or the Mayo Clinic. Dr. Rocca was partly funded by the Ralph S. and Beverley E. Caulkins Professorship of Neurodegenerative Diseases Research of the Mayo Clinic. Ms. Smith and Drs. Gazzuola Rocca, Kapoor, Faubion, and Stewart did not receive external funding for this study.Elizabeth A. Stewart has no competing interest directly related to the subject of this paper. However, over the past 36 months she has the following conflicts of interest: She has been a consultant for AbbVie, Bayer, ObsEva, and Myovant related to uterine fibroids. She receives active research support regarding adenomyosis (R01 HD105714) from the Eunice Kennedy Shiver Institute of Child Health and Human Development, National Institutes of Health. She has received research support from AHRQ and PCORI related to uterine fibroids (P50 HS023418) and holds a patent for Methods and Compounds for Treatment of Abnormal Uterine Bleeding (US 6440445), which has no commercial activity. She has received royalties from UpToDate and payments for the development of educational content from the Med Learning Group, PER, Massachusetts Medical Society, and Peer View.
Funding Information:
Funding for this study was provided by the grants U54 AG044170 and RF1 AG055151 from the National Institute on Aging/National Institutes of Health. In addition, this study used the resources of the Rochester Epidemiology Project (REP) medical records-linkage system, which is supported by the National Institute on Aging ( R33 AG058738 ), by the Mayo Clinic Research Committee, and by fees paid annually by REP users. However, the content of this article is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health (NIH) or the Mayo Clinic. Dr. Rocca was partly funded by the Ralph S. and Beverley E. Caulkins Professorship of Neurodegenerative Diseases Research of the Mayo Clinic. Ms. Smith and Drs. Gazzuola Rocca, Kapoor, Faubion, and Stewart did not receive external funding for this study.
Publisher Copyright:
© 2023 Elsevier B.V.
PY - 2023/4
Y1 - 2023/4
N2 - Objective: There is limited information on the prevalence of premature and early menopause. Therefore, we studied the frequency and type of premature (age < 40 years) or early (age 40–44 years) menopause in a geographically-defined American population. Methods: We studied a random sample of women aged 18 to 50 years who resided in Olmsted County, MN between 1988 and 2007. Women were followed through December 2021, and age at cessation of menses was assessed via review of the medical records included in a medical records-linkage system. Menopause was defined as cessation of menses due to spontaneous or induced ovarian insufficiency. Results: 1015 women (71.3 %) underwent spontaneous menopause, 138 (9.7 %) underwent bilateral oophorectomy, 17 (1.2 %) had antecedent chemotherapy or radiation therapy, and 254 (17.8 %) underwent hysterectomy or endometrial ablation. The median age at cessation of menses was 51.0 years (IQR, 49.0–52.0) for spontaneous menopause, 46.0 years (IQR, 41.0–49.0) for menopause induced by oophorectomy, chemotherapy, or radiation therapy, and 38.0 years (IQR, 33.0–44.0) for hysterectomy. Considering both spontaneous and induced menopause, the frequency was 3.1 % (95 % CI, 2.2–4.2) for premature and 6.2 % (95 % CI, 5.0–7.8) for early menopause. Considering only spontaneous menopause, the frequency reduced to 0.4 % (95 % CI, 0.2–1.0) for premature and 5.2 % (95 % CI, 4.0–6.8) for early menopause. However, considering all types of cessations of menses, the frequency was 12.2 % (95 % CI, 10.6–14.0) for premature and 9.7 % (95 % CI, 8.3–11.3) for early cessation of menses. Discussion: Approximately 3 % of women in the general population experienced either spontaneous or induced premature menopause. The most common cause of premature menopause was bilateral oophorectomy.
AB - Objective: There is limited information on the prevalence of premature and early menopause. Therefore, we studied the frequency and type of premature (age < 40 years) or early (age 40–44 years) menopause in a geographically-defined American population. Methods: We studied a random sample of women aged 18 to 50 years who resided in Olmsted County, MN between 1988 and 2007. Women were followed through December 2021, and age at cessation of menses was assessed via review of the medical records included in a medical records-linkage system. Menopause was defined as cessation of menses due to spontaneous or induced ovarian insufficiency. Results: 1015 women (71.3 %) underwent spontaneous menopause, 138 (9.7 %) underwent bilateral oophorectomy, 17 (1.2 %) had antecedent chemotherapy or radiation therapy, and 254 (17.8 %) underwent hysterectomy or endometrial ablation. The median age at cessation of menses was 51.0 years (IQR, 49.0–52.0) for spontaneous menopause, 46.0 years (IQR, 41.0–49.0) for menopause induced by oophorectomy, chemotherapy, or radiation therapy, and 38.0 years (IQR, 33.0–44.0) for hysterectomy. Considering both spontaneous and induced menopause, the frequency was 3.1 % (95 % CI, 2.2–4.2) for premature and 6.2 % (95 % CI, 5.0–7.8) for early menopause. Considering only spontaneous menopause, the frequency reduced to 0.4 % (95 % CI, 0.2–1.0) for premature and 5.2 % (95 % CI, 4.0–6.8) for early menopause. However, considering all types of cessations of menses, the frequency was 12.2 % (95 % CI, 10.6–14.0) for premature and 9.7 % (95 % CI, 8.3–11.3) for early cessation of menses. Discussion: Approximately 3 % of women in the general population experienced either spontaneous or induced premature menopause. The most common cause of premature menopause was bilateral oophorectomy.
KW - Age at menopause
KW - Bilateral oophorectomy
KW - Cessation of menses
KW - Early menopause, premature ovarian insufficiency
KW - Hysterectomy
KW - Premature menopause
UR - http://www.scopus.com/inward/record.url?scp=85147832529&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147832529&partnerID=8YFLogxK
U2 - 10.1016/j.maturitas.2023.01.012
DO - 10.1016/j.maturitas.2023.01.012
M3 - Article
C2 - 36753871
AN - SCOPUS:85147832529
SN - 0378-5122
VL - 170
SP - 22
EP - 30
JO - Maturitas
JF - Maturitas
ER -